Global impairment of CD4+CD25+FOXP3+ regulatory T cells in idiopathic pulmonary fibrosis

American Journal of Respiratory and Critical Care Medicine

Volumn 179, Issue 12, 2009, Pages 1121-1130

  Kotsianidis, Ioannis ^a,c   Nakou, Evangelia ^a   Bouchliou, Irene ^a   Tzouvelekis, Argyrios ^a   Spanoudakis, Emmanouil ^a   Steiropoulos, Paschalis ^a   Sotiriou, Ioannis ^a   Aidinis, Vassilis ^b   Margaritis, Dimitrios ^a   Tsatalas, Costas ^a   Bouros, Demosthenes ^a  

^a DEMOCRITUS UNIVERSITY OF THRACE MEDICAL SCHOOL   (Greece)

^b BIOMEDICAL SCIENCES RESEARCH CENTER ALEXANDER FLEMING   (Greece)

^c DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

Author keywords

Bronchoalveolar lavage; Idiopathic pulmonary fibrosis; Pulmonary function tests; Tregs

Indexed keywords

ANTIOXIDANT; PREDNISONE; TRANSCRIPTION FACTOR FOXP3;

ADULT; AGED; ARTICLE; BLOOD; CD4+ CD25+ T LYMPHOCYTE; CELL PROLIFERATION; CELL SUSPENSION; COLLAGEN DISEASE; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE SEVERITY; FEMALE; FIBROSING ALVEOLITIS; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LOW DRUG DOSE; LUNG DISEASE; LUNG FUNCTION; LUNG LAVAGE; LYMPHOCYTE FUNCTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SPIROMETRY; TH1 CELL; TH2 CELL; VASCULAR DISEASE;

ADULT; AGED; AGED, 80 AND OVER; BRONCHOALVEOLAR LAVAGE FLUID; CELL PROLIFERATION; CYTOKINES; FEMALE; FLOW CYTOMETRY; FOLLOW-UP STUDIES; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; IDIOPATHIC PULMONARY FIBROSIS; IMMUNITY, CELLULAR; IMMUNOPHENOTYPING; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; MALE; MIDDLE AGED; RESPIRATORY FUNCTION TESTS; T-LYMPHOCYTES, REGULATORY; YOUNG ADULT;

EID: 67449083692     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.200812-1936OC     Document Type: Article

References (52)

1. American Thoracic Society, European Respiratory Society. American Thoracic Society/European Respiratory Society international multidisciplinary consensus classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 2002;165:277-304. (Pubitemid 34084471)
2. Raghu G, Weycker D, Edelsberg J, Bradford WZ, Oster G. Incidence and prevalence of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2006;174:810-816. (Pubitemid 44511663)
3. Selman M, King TE, Pardo A. Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy. Ann Intern Med 2001;134:136-151. (Pubitemid 32096342)
4. Tzouvelekis A, Harokopos V, Paparountas T, Oikonomou N, Chatziioannou A, Vilaras G, Tsiambas E, Karameris A, Bouros D, Aidinis V. Comparative expression profiling in pulmonary fibrosis suggests a role of hypoxia-inducible factor-1α in disease pathogenesis. Am J Respir Crit Care Med 2007;176:1108-1119. (Pubitemid 350223757)
5. Jindal SK, Agarwal R. Autoimmunity and interstitial lung disease. Curr Opin Pulm Med 2005;11:438-446.
6. Luzina IG, Todd NW, Iacono AT, Atamas SP. Roles of T lymphocytes in pulmonary fibrosis. J Leukoc Biol 2008;83:237-244. (Pubitemid 351225603)
7. Homolka J, Ziegenhagen MW, Gaede KI, Entzian P, Zissel G, Muller-Quernheim J. Systemic immune cell activation in a subgroup of patients with idiopathic pulmonary fibrosis. Respiration 2003;70:262-269. (Pubitemid 36980770)
8. Shimizudani N, Murata H, Keino H, Kojo S, Nakamura H, Morishima Y, Sakamoto T, Ohtsuka M, Sekisawa K, Sumida M, et al. Conserved CDR 3 region of T cell receptor BV gene in lymphocytes from bronchoalveolar lavage fluid of patients with idiopathic pulmonary fibrosis. Clin Exp Immunol 2002;129:140-149.
9. Feghali-Bostwick CA, Tsai CG, Valentine VG, Kantrow S, Stoner MW, Pilewski JM, Gadgil A, George MP, Gibson KF, Choi AM, et al. Cellular and humoral autoreactivity in idiopathic pulmonary fibrosis. J Immunol 2007;179:2592-2599.
10. Fireman E, Vardinon N, Burke M, Spizer S, Levin S, Endler A, Stav D, Topilsky M, Mann A, Schwarz Y, et al. Predictive value of response to treatment of T-lymphocyte subpopulations in idiopathic pulmonary fibrosis. Eur Respir J 1998;11:706-711. (Pubitemid 28194866)
11. Daniil Z, Kitsanta P, Kapotsis G, Mathioudaki M, Kollintza A, Karatza M, Milic-Emili J, Roussos C, Papiris SA. CD8+ T lymphocytes in lung tissue from patients with idiopathic pulmonary fibrosis. Respir Res 2005;6:81. (Pubitemid 41410155)
12. Strieter RM. Pathogenesis and natural history of usual interstitial pneumonia: the whole story or the last chapter of a long novel. Chest 2005;128:526S-532S.
13. + regulatory t cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immunol 2004;22:531-562.
14. von Boehmer H. Mechanisms of suppression by suppressor T cells. Nat Immunol 2005;6:338-344. (Pubitemid 41716770)
15. Ehrenstein MR, Evans JG, Singh A, Moore S, Warnes G, Isenberg DA, Mauri C. Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFα therapy. J Exp Med 2004;200:277-285. (Pubitemid 39031247)
16. high T regulatory cell function in patients with active systemic lupus erythematosus. J Immunol 2007;178:2579-2588.
17. + regulatory T cells in patients with multiple sclerosis. J Exp Med 2004;199:971-979.
18. + regulatory T cells in autoimmune polyglandular syndrome type II. J Exp Med 2004;199:1285-1291.
19. + T cell levels in NOD mice. Proc Natl Acad Sci USA 2002;99:12287-12292.
20. + regulatory T cells suppress antigen-specific autoreactive immune responses and central nervous system inflammation during active experimental autoimmune encephalomyelitis. J Immunol 2002;169:4712-4716.
21. + regulatory T cells in transplantation: progress, challenges and prospects. Am J Transplant 2007;7:1457-1463.
22. Miyara M, Amoura Z, Parizot C, Badoual C, Dorgham K, Trad S, Kambouchner M, Valeyre D, Chapelon-Abric C, Debre P, et al. The immune paradox of sarcoidosis and regulatory T cells. J Exp Med 2006;203:359-370. (Pubitemid 43290845)
23. + regulatory T cells in autoimmune diseases. Nat Clin Pract Rheumatol 2007;3:619-626.
24. Nakou EFM, Tzouvelekis A, Steiropoulos P, Bouchliou I, Kotsianidis I, Bouros D. Local expansion of Tregs: a common link in the pathogenesis of IPF and NSIP [abstract]. Am J Respir Crit Care Med 2007;175:A986.
25. Guyot-Revol V, Innes JA, Hackforth S, Hinks T, Lalvani A. Regulatory T cells are expanded in blood and disease sites in patients with tuberculosis. Am J Respir Crit Care Med 2006;173:803-810.
26. Antoniou KM, Tzouvelekis A, Alexandrakis MG, Sfiridaki K, Tsiligianni I, Rachiotis G, Tzanakis N, Bouros D, Milic-Emili J, Siafakas NM. Different angiogenic activity in pulmonary sarcoidosis and idiopathic pulmonary fibrosis. Chest 2006;130:982-988. (Pubitemid 44583725)
27. + regulatory T cells in patients with multiple myeloma. Blood 2006;107:3940-3949.
28. Baecher-Allan C, Hafler DA. Human regulatory T cells and their role in autoimmune disease. Immunol Rev 2006;212:203-216. (Pubitemid 44116710)
29. + regulatory T cells in myelodysplastic syndrome (MDS). Blood 2007;110:847-850.
30. + T cells in B-cell non-Hodgkin lymphoma. Blood 2006;107:3639-3646.
31. pos regulatory T cells differentiate into IL-17-producing cells. Blood 2008;112:2340-2352.
32. + T helper cells. J Exp Med 2002;196:255-260.
33. + T cells with regulatory properties isolated from peripheral blood. J Exp Med 2001;193:1285-1294.
34. Martinez FJ, Flaherty K. Pulmonary function testing in idiopathic interstitial pneumonias. Proc Am Thorac Soc 2006;3:315-321. (Pubitemid 43845408)
35. + regulatory T-cell deficiency in patients with hepatitis C-mixed cryoglobulinemia vasculitis. Blood 2004;103:3428-3430.
36. + regulatory T cells in systemic lupus erythematosus. Rheumatology (Oxford) 2008;47:789-794.
37. Miyara M, Amoura Z, Parizot C, Badoual C, Dorgham K, Trad S, Nochy D, Debre P, Piette JC, Gorochov G. Global natural regulatory T cell depletion in active systemic lupus erythematosus. J Immunol 2005;175:8392-8400. (Pubitemid 41798406)
38. low regulatory T cell (Treg) development and function are disturbed in multiple sclerosis patients: recovery of memory Treg homeostasis during disease progression. J Immunol 2008;180:6411-6420.
39. + regulatory T cells in the control of autoimmunity: in vivo veritas. Curr Opin Immunol 2008;20:655-662.
40. + Treg development and function during allergic airway inflammation in vivo. J Clin Invest 2005;115:313-325.
41. + regulatory T cells is interleukin 10 dependent. J Exp Med 2005;202:1539-1547.
42. Wan YY, Flavell RA. Regulatory T-cell functions are subverted and converted owing to attenuated Foxp3 expression. Nature 2007;445:766-770. (Pubitemid 46279706)
43. Chatila TA, Blaeser F, Ho N, Lederman HM, Voulgaropoulos C, Helms C, Bowcock AM. JM2, encoding a fork head-related protein, is mutated in X-linked autoimmunity-allergic dysregulation syndrome. J Clin Invest 2000;106:R75-R81. (Pubitemid 32038594)
44. H2 paradigm. Nat Rev Immunol 2004;4:583-594.
45. Clark RA, Kupper TS. IL-15 and dermal fibroblasts induce proliferation of natural regulatory T cells isolated from human skin. Blood 2007;109:194-202. (Pubitemid 46053061)
46. Senechal B, Elain G, Jeziorski E, Grondin V, Patey-Mariaud de Serre N, Jaubert F, Beldjord K, Lellouch A, Glorion C, Zerah M, et al. Expansion of regulatory T cells in patients with Langerhans cell histiocytosis. PLoS Med 2007;4:e253. (Pubitemid 47358173)
47. + lymphocyte recruitment after lipopolysaccharide endotoxemia in mouse lung. J Thromb Haemost 2007;5:2467-2475.
48. Eitzman DT, McCoy RD, Zheng X, Fay WP, Shen T, Ginsburg D, Simon RH. Bleomycin-induced pulmonary fibrosis in transgenic mice that either lack or overexpress the murine plasminogen activator inhibitor-1 gene. J Clin Invest 1996;97:232-237. (Pubitemid 26021713)
49. Hamdi H, Godot V, Maillot MC, Prejean MV, Cohen N, Krzysiek R, Lemoine FM, Zou W, Emilie D. Induction of antigen-specific regulatory T lymphocytes by human dendritic cells expressing the glucocorticoid-induced leucine zipper. Blood 2007;110:211-219. (Pubitemid 47026837)
50. Karagiannidis C, Akdis M, Holopainen P, Woolley NJ, Hense G, Ruckert B, Mantel PY, Menz G, Akdis CA, Blaser K, et al. Glucocorticoids upregulate FOXP3 expression and regulatory T cells in asthma. J Allergy Clin Immunol 2004;114:1425-1433. (Pubitemid 39575901)
51. Torgerson TR, Ochs HD. Immune dysregulation, polyendocrinopathy, enteropathy, X-linked: forkhead box protein 3 mutations and lack of regulatory T cells. J Allergy Clin Immunol 2007;120:744-750. (quiz 751-742). (Pubitemid 47531861)
52. Roncarolo MG, Battaglia M. Regulatory T-cell immunotherapy for tolerance to self antigens and alloantigens in humans. Nat Rev Immunol 2007;7:585-598. (Pubitemid 47123554)